299 filings
Page 2 of 15
6-K
51v2 2dc5bxliphikj
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
6-K
x2s00wnfpm5bqd2oj
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
ngi23vm8xonr09 zjj68
31 May 23
Report of Foreign Private Issuer
8:09am
6-K
2nsy51
8 May 23
Enlivex Announces Issuance of European Patent Covering the Use of Allocetra™ to
8:02am
6-K
w219fkea
19 Apr 23
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
8:03am
6-K
qaipf2g8pglcerx3sqj8
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
93nx01 cyjb
4 Apr 23
Enlivex Announces Tislelizumab Clinical Collaboration, Full Year 2022 Financial Results, and Provides Business Updates
8:05am
6-K
jqs5mm
3 Apr 23
Enlivex Announces Clinical Collaboration to Evaluate Combinations of Allocetra and PD-1 Inhibitor Tislelizumab for Patients with Solid Tumors
8:05am
6-K
3z1rlff2y mpaq
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
ee4eq1ddl64 f833y7ih
20 Mar 23
Report of Foreign Private Issuer
8:02am
6-K
rvwktuvxq68ob7cl
23 Feb 23
Report of Foreign Private Issuer
8:02am
6-K
hbm4qdb os3yv8cj2i
15 Feb 23
Enlivex Announces Issuance of Israeli Patent Covering the Use of Allocetra™ to
8:02am
6-K
ik6 d2utu
25 Jan 23
Enlivex Announces Positive DSMB Recommendation and IMOH Clearance to Continue Phase I/II Trial of Allocetra in Patients with Advanced Solid Tumors
8:43am
6-K
icv xqxdhcs79z0
4 Jan 23
Enlivex Receives Authorizations from French and Belgian Regulatory Agencies To Expand Its Phase II Sepsis Clinical Trial Into France and Belgium
8:05am
6-K
rwjrugl1f69dbeu27zab
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
zinq5h
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
9n2byd84ynqz bsxvb5o
5 Dec 22
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
8:05am
6-K
nx57b7j7iy43
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
umpbhv s9dm5
28 Nov 22
Enlivex Receives Allocetra IND Clearance From The U.S. Food And Drug Administration For Treatment Of Patients with Advanced Solid Malignancies
8:01am